chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I contracted COVID-19 on 05/19/2022 with sore throat, itchy throat, sneezing, congestion, and headache. I was prescribed PAXLOVID on 05/20/2022 via a telemedicine visit. I was ill for 8 days before my symptoms resolved. I flew to another area 05/29/2022 and my COVID-19 symptoms returned that evening and worsened. My sputum was no longer clear and eventually was a magenta color, which made me concerned it was blood. The congestion was far worse, and I had to have another medical visit where I was given a Z-PAK on 06/05/2022. On 06/06/2022 I was not feeling improved at all so I had a HCF do a home call where they gave me a steroid shot and an albuterol inhaler prescription. I felt much better after that and my symptoms fully resolved after 8 days. I do feel my memory has been affected by my illness.
This spontaneous report as received from a 78 years old female patient with allergies to TEQUIN, mobeck, Sulfur and CIPRO. "Five years ago" in approximately September 2007, the patient was vaccinated subcutaneously with a single dose of ZOSTAVAX (Lot# and dose not reported). In April 2012 the patient experienced a diagnosed case of the shingles after getting the vaccine. She had the shingles on her back, but stated it was a mild case. The patient sought for unspecified medical attention and was given oral medications for treatment. The patient's status was not reported. Additional information has been requested.
Activated a BAKERS SYSTS; she could not get up, she could not go to bathroom; Left leg was very sore; Left leg very swollen; Chills; Had fever; Inconsistencies to remember; Not feel well; Delirious; A spontaneous report was received from a consumer concerning 88-years-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced bad reaction, began to not feel well, had fever, was delirious, inconsistencies with speech, problems with the left leg, left leg was very sore, very swollen, could not get up, had chills, couldn't sit in the bathroom, overreaction and activated a Baker's cyst  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 16 Feb 2021, approximately three hours prior to the onset of the events, the patient received their second of two planned doses of mRNA-1273 (Batch Number 032L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 16 Feb 2021, the patient experienced to not feel well, had fever, was delirious(considered medically significant event), inconsistencies to remember, problems with the left leg. On Wednesday 17 Feb 2021, the patient experienced left leg was very sore, very swollen, could not get up, could not go to the bathroom, had a fever and chills. On Thursday 18 Feb 2021, the patient experienced could not sit in the bathroom. On Friday 19 Feb 2021, the patient was still very swollen. On an unknown date, the patient experienced activated a BAKERS SYSTS  Laboratory details included, on Saturday 20 Feb 2021, the patient went to the hospital and got an ECO DOPPLER.  Treatment for the event included Ibuprofen.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events, bad reaction, began to not feel well, she had a fever, she was delirious, said inconsistencies, problems with the left leg, left leg was very sore, very swollen, could not get up, could not go to the bathroom,  had a fever and chills, couldn't sit in the bathroom, overreaction and activated a BAKERS SYSTS was considered recovering(getting better every day).; Reporter's Comments: Based on the current available information and  a temporal association between the use of the product and the start date of the event and excluding all other etiologies, a causal relationship cannot be excluded.
This spontaneous report as received from a pharmacist refers to a 26 year old female patient. No medical history reported. Past drug history was unknown. On 25-AUG-2014 the patient was vaccinated with a dose of PNEUMOVAX 23 (1 injection once in the right deltoid, lot # J009827, indication: heavy smoking) that expired on 10-AUG-2014. No concomitant medications reported. It was unknown if there was any relevant laboratory data. On 25-AUG-2014 it was unknown if the patient would receive PNEUMOVAX 23 again. The patient was fine after being administered an expired vaccine. Additional information has been requested.
Information has been received from a healthcare worker referring to an unspecified number of children of unknown age and gender. On unknown dates, the children were vaccinated with improperly stored doses of RECOMBIVAX HB (lot number, dose and route were unknown). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information is not expected because the reporter did not want to be contacted.
Skin is hot where hives are; Had hives again started on her arms and spread all the way to her neck and trunk; Headache also; Fever with this one also but not quite as high; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Had hives again started on her arms and spread all the way to her neck and trunk), SKIN WARM (Skin is hot where hives are), HEADACHE (Headache also) and PYREXIA (Fever with this one also but not quite as high) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040C21A and 036C21A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy NOS. Concomitant products included DESOGESTREL (JULIET) for Birth control, CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for an unknown indication.   On 29-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Jul-2021, the patient experienced HEADACHE (Headache also) and PYREXIA (Fever with this one also but not quite as high). On 31-Jul-2021, the patient experienced URTICARIA (Had hives again started on her arms and spread all the way to her neck and trunk). On 02-Aug-2021, the patient experienced SKIN WARM (Skin is hot where hives are). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 02-Aug-2021, URTICARIA (Had hives again started on her arms and spread all the way to her neck and trunk) was resolving. At the time of the report, SKIN WARM (Skin is hot where hives are), HEADACHE (Headache also) and PYREXIA (Fever with this one also but not quite as high) outcome was unknown.            This case was linked to MOD-2021-273064 (Patient Link).
Patient presented to the Health Department wanting a booster shot. Patient stated he last had his booster in September 2022. Secretary double checked and confirmed date. Bivalent Booster given on 01/20/2023, however it was then learned his last booster in September of 2022 was also a Bivalent so patient has received 2 bivalent boosters.  After learning this patient has not reported any adverse reactions
Spontaneous eruption erythematous raised lesions with 5 cent vesicular centers - Appearing in crops and increasing (-) other symptoms
a sore arm; caller received first dose on left arm; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (caller received first dose on left arm) and PAIN IN EXTREMITY (a sore arm) in a 36-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 12-Feb-2021 and the estimated date of delivery was 19-Nov-2021. On 26-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (caller received first dose on left arm). On 26-Mar-2021, the patient experienced PAIN IN EXTREMITY (a sore arm). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  second week of the pregnancy.  On 26-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (caller received first dose on left arm) had resolved. At the time of the report, PAIN IN EXTREMITY (a sore arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Mar-2021, Pregnancy test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reported Full term child birth on 09Sep2019 in history. Treatment information does not provided.
Pt's wife called on 9-13-11 & stated pt's rt arm was hurting severely where he received his vaccine. He was unable to move his arm. Onset 9-12-11 at 10pm. Dr prescribed pain meds for the pain.
Bad Headache, Fatigue laid down, fell asleep 2 hours, woke up with chills.
This spontaneous report as received from a registered nurse refers to a 73 year old female patient with asthma, fibromyalgia, hypertension, osteoporosis, neurogenic claudication, osteoarthritis, sulfa allergy and doxycycline allergy. The nurse reported the patient received an initial dose of PNEUMOVAX 23, (Lot # K004148, Exp date 10-MAY-2015) intramuscular on 26-DEC-2007, then was revaccinated "due to a history of asthma" on 11-SEP-2014. Concomitant therapies included metoprolol, DYAZIDE, tramadol hydrochloride, ipratropium bromide and triamcinolone. On 11-SEP-2014, the patient experienced injection site pain, redness and swelling immediately following this injection. The patient sought medical attention by office visit and was treated with BENADRYL and TYLENOL. The patient recovered on "about 12-DEC-2014." No additional information provided. Additional information has been requested.
started having to clear throat; vocal changes; semi-wet cough; This is a spontaneous report from a contactable consumer. A 70-Year-Old Female Patient (non-pregnant) received first dose of of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EN8202), via an unspecified route of administration, administered at left arm, on 28Feb2021, 11:00 AM at single dose for COVID-19 immunisation. Patient medical history included cancer, lymphocytic colitis and PI 1 deficiency. Patient was known to allergies reactions. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications were not reported. The patient did not received other medications within 2 weeks of vaccination. On 28Feb2021, 45 min after administration, patient started having to clear throat, with vocal changes (hoarse voice went to a squeeky voice) with constant clearing of throat and semi-wet cough. Patient was treated with Benadryl, Epinephrine injectable and prednisolone. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient was not tested for COVID-19. The outcome of the evens are recovered on 28Feb2021.  No follow up attempts are possible. No further information is expected.
Collapsed and had convulsions. Was lightheaded and Became completely pale and lips turned white
I contracted COVID19 approx 2 months after the Pfizer booster (4th shot).  Symptoms were sore throat, runny nose, fever and chills, brain fog.  Took an at home antigentest  on 7/7/2022 and it was positive.  Had a tele-medecine visit on 7/8/2022 and was prescribed Paxlovid.  It substantially reduced the symptoms. Only side effect of the Paxlovid was bad taste.  No rebound after completing Paxlovid.  Tested negative on at home test starting 7/13/2022.
COVID19 Pfizer vaccine indicated for ages >12 administered.  Patient family contacted.  No adverse events noted.
The adverse event is a medication error of giving the vaccine undiluted, the patinet was informed that a wrong dose was given, a more concentrated dose than normal, educated and instruction on what symptoms he may have in the next 24 hours - increased swelling or redness in arm, flu-like symptoms, to call in or come to ED if any concerning symptoms occur, that we will call him back in 24 hours to check on him.  Patient reports no side effects at this time (7:28 pm)
Pt. said 4 days after receiveing vaccine injection site was red, swollen, and sore. It was not the days after vaccine.
w/in a few hrs p/immun pt exp a large lump (size of an orange) @ the site of inject; no fever; no systemic reaction;
pt recvd vax & several hrs later devel redness & swelling @ the inj site; pt devel numbness & tingling in the injected lt arm; later that day devel twitching in lt leg which resolved w/in 2 hrs; next morning exp diarrhea
R Arm still hurting and worse this last week than first week. Impeding movement and it's been 15 days which just seems a little excessive for a shot. Normally shots hurt for a day or day and a half for me
full body paralyzation; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PARALYSIS (full body paralyzation) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PARALYSIS (full body paralyzation) (seriousness criterion medically significant). At the time of the report, PARALYSIS (full body paralyzation) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.  Company Comment: Very limited information regarding this event has been provided at this time.  However, based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Very limited information regarding this event has been provided at this time.  However, based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
About 5 minutes after the shot, I started to feel a tightness in my throat.  It lasted a couple of minutes and then passed. Then about 45 minutes after I started to feel a heaviness/ache in my upper chest. This feeling continued for days. Around day four I began to have a feeling of great pressure in my throat, particularly when swallowing. I noticed that my heartrate was elevated, but that might have been because the feeling was very stressful.  The feeling would increase when I turned my head to the side or put my chin down.This feeling persisted for 3 days. After three days the feeling changed slightly and started feeling more like the sensation one gets when you have food stuck in your throat. As I type this, it is 8 days after the vaccine and I still feel this sensation in my throat.
This spontaneous case, was received on 20-Oct-2017 from a pharmacist, concerns a 06-year-old, male child. This refers to 03 out of 04 reports. On 10-Oct-2017, the patient was administered with FLUCELVAX QIV (dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid, batch no: 195216 and expiry date: Apr-2018). It was reported that, the influenza vaccine was left out of the refrigerator for a couple of days and temperature had reached maximum of 72F to 90 hours. The same vaccine was administered to the patient. It was reported that, the patient did not experience any adverse effects after the administration of the vaccine. The reporter assessed the case as non-serious. Significant case correction received on 20-Oct-2017: The event inappropriate age at vaccine administration was deleted. Narrative amended accordingly. Follow up received on 26-Oct-2017: New event (no adverse event) was added. It was reported that, the patient did not experience any adverse effects after the administration of the vaccine. The narrative was amended accordingly. Significant case correction received with IRD 26-Oct-2017: The event 'no adverse event' was deleted.
Initial exposure, pain @ the inject site to the fingers of the lt hand 2APR93; 3APR93 hives over entire body causing itching & severe lower back pain upon rising x 1 day; 2 large blotches observed by employee;
Notified that the employee who had received Moderna COVID-19 vaccination approximately 32 minutes prior to notification of this NP began complaining of lip swelling, tongue tingling and itching in mouth and mild headache, reported sensation of "full lips". Employee had been advised to wait 30 minutes after administration of vaccine due to known hx of allergic reaction to requiring use of Epi-pen per CDC and manufacturer guidelines. Employee noted to carry Epi-Pen due to prior allergic reaction from walking through "cloud" of sulfa dust in the lab where she was working at previous employer. Denied SOB, cough, tongue swelling, rash, N/V/D, abdominal or chest pain. Stated she was not sure if reaction is due to her anxiety or to possible reaction to the vaccine.  2:36pm: VS BP 118/70, p 82, 02 sat 98%, Resp. 18  2:42pm: VS BP 116/74, p 76, 02 sat 98%, Resp. 16 HEENT: no edema/erythema oropharynx, uvula midline; airway patent, mild edema right lower lip. Resp: LSC. Skin: No urticaria or erythema. Employee had personal liquid Zyrtec; took 10mg PO and single ampule of personal Cromolyn Sodium with complete resolution of sxs in approx 15 minutes after administration. Advised employee of need for f/u for medical possible allergic reaction; refused EMS/ED; advised of possible bi-phasic response and risk; continued to decline EMS/ED. Employee called PCP office; triage RN advised ED rather than UC. Medical Director for Health Center in to evaluate patient; case reviewed, care transferred to Dr. Discharged per Dr.; follow-up with PCP/allergist.
Severe stomach pain; Swollen glands; Vomiting; Severe headache; Severe fatigue; Knot in arm; Sore arm; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 26Mar2021 at 08:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included fibromyalgia. It was unknown whether the patient had any allergies to medications, food, or other products. Concomitant medications included ziprasidone (MANUFACTURER UNKNOWN), clonazepam (MANUFACTURER UNKNOWN) and fluoxetine (MANUFACTURER UNKNOWN) on an unknown date for an unknown indication. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 05Mar2021 at 08:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Mar2021, right after second dose, the patient experienced sore arm and knot in arm (muscle spasm). On 28Mar2021 at 20:00, two days after second dose, the patient experienced severe fatigue and severe headache. On 02Apr2021, one week after second dose, the patient experienced vomiting, severe stomach pain, swollen glands and severe fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported adverse events. The clinical outcome of the event sore arm, knot in arm (muscle spasm), severe fatigue, severe headache, vomiting, severe stomach pain and swollen glands was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
since I got the second dose on 29Jan21 the shortness of breath has been worse, it's been more frequent, when I'm doing minor activities I'm getting out of breath really quick; since I got the second dose on 29Jan21 the shortness of breath has been worse, it's been more frequent, when I'm doing minor activities I'm getting out of breath really quick; This is a spontaneous report from a contactable consumer or other non hcp. A male patient of an unspecified age received  second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration on 29Jan2021 as single dose for covid-19 immunization. The patient had historical vaccine (BNT162B2) and dose 1 and experienced shortness of breath and very sore arm. The patient's concomitant medications were not reported. It was reported that since patient got the second dose on 29Jan2021, the shortness of breath has been worse, it's been more frequent, when he was doing minor activities. He was getting out of breath really quick on Jan2021. Outcome of the events was unknown.  Information on lot number/batch number has been requested.
No adverse event; Vaccine administered after BUD of 07-Jul-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered after BUD of 07-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 4-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1414B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 09-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered after BUD of 07-Jul-2022). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine administered after BUD of 07-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Vaccine administered after BUD of 07-Jul-2022).    CIIS ID reported for the patient.  Concomitant product use was not provided by the reporter.   Vaccine was received at vaccination Centre on 07-Jun-2022 and before use date was reported as 07-Jul-2022.  Treatment information was not reported.